News & Updates

Show Multimedia Only

Adding low-dose aspirin to calcium does not prevent pre-eclampsia in high-risk pregnancies

25 Jun 2025

Treatment with low-dose aspirin, when added to calcium, early in pregnancy does not appear to provide any benefit in terms of reducing the incidence of pre-eclampsia as well as caesarean section or other important neonatal outcomes in high-risk women, according to a study.

Adding low-dose aspirin to calcium does not prevent pre-eclampsia in high-risk pregnancies

25 Jun 2025

Erenumab of no benefit to patients with chronic cluster headache

24 Jun 2025

Calcitonin gene-related peptide (CGRP) receptor blockade with erenumab does not appear to reduce the weekly frequency of cluster headache attacks, as shown in a study from Germany.

Erenumab of no benefit to patients with chronic cluster headache

24 Jun 2025

Real-world data captures risk of major cardiac events with cannabis use

24 Jun 2025 by

Cannabis users are at increased risk of major adverse cardiovascular events (MACE), according to the results of a meta-analysis based on real-world data.

Real-world data captures risk of major cardiac events with cannabis use

24 Jun 2025

Esaxerenone improves vascular function, peripheral arterial stiffness in IHA patients

24 Jun 2025

Patients with idiopathic hyperaldosteronism (IHA) treated with esaxerenone show improved vascular function and reduced peripheral arterial stiffness, reports a study.

Esaxerenone improves vascular function, peripheral arterial stiffness in IHA patients

24 Jun 2025

Ultrasonic propulsion clears residual stone fragments in kidney

24 Jun 2025 by

More patients who underwent ultrasonic propulsion (UP), facilitated by an independent group of operators, benefit from the passage of residual kidney stone fragments and from a decreased stone burden than those who did not receive treatment, a recent trial has shown.

Ultrasonic propulsion clears residual stone fragments in kidney

24 Jun 2025

Obesity in polytrauma patients appears protective vs death

24 Jun 2025

Polytrauma patients with obesity appear to have a lower risk of death and shorter length of hospital stays, suggests a study.

Obesity in polytrauma patients appears protective vs death

24 Jun 2025

Perioperative pembrolizumab may shift treatment paradigm in resectable HNSCC

24 Jun 2025 by

In the first interim analysis of the phase III KEYNOTE-689 trial, pembrolizumab improves event-free survival (EFS) and major pathological response (mPR) rate, independent of CPS*, when added to standard-of-care (SoC) treatment for resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC).

Perioperative pembrolizumab may shift treatment paradigm in resectable HNSCC

24 Jun 2025

Injectable extended-release naltrexone poses no hepatotoxicity signal in advanced ALD

24 Jun 2025

The use of the injectable extended-release naltrexone for alcohol use disorder in patients with advanced alcohol-associated liver disease (ALD) does not appear to carry a substantial hepatotoxicity or liver decompensation risk, according to a study.

Injectable extended-release naltrexone poses no hepatotoxicity signal in advanced ALD

24 Jun 2025

The link between microbes and the gut is being brought to light with the power of AI.

24 Jun 2025 by

Former Dean of the Faculty of Medicine at The Chinese University of Hong Kong (CUHK), Choh-Ming Li Professor of Medicine and Therapeutics, codirector of Microbiota I-Center (MagIC), Gastroenterologist

The link between microbes and the gut is being brought to light with the power of AI.

24 Jun 2025

ARANOTE: Darolutamide positively impacts HRQoL in men with mHSPC

24 Jun 2025 by

Darolutamide demonstrated clinically meaningful delays in pain progression and deterioration of important patient-relevant health-related quality of life (HRQoL) outcomes vs placebo in men with metastatic hormone-sensitive prostate cancer (mHSPC), according to phase III ARANOTE trial findings presented at ASCO 2025. [ASCO 2025, abstract 5004]

ARANOTE: Darolutamide positively impacts HRQoL in men with mHSPC

24 Jun 2025

News & Updates

Filter by Specialty:

Specialty:

Adding low-dose aspirin to calcium does not prevent pre-eclampsia in high-risk pregnancies

Adding low-dose aspirin to calcium does not prevent pre-eclampsia in high-risk pregnancies

Erenumab of no benefit to patients with chronic cluster headache

Erenumab of no benefit to patients with chronic cluster headache

Real-world data captures risk of major cardiac events with cannabis use

Real-world data captures risk of major cardiac events with cannabis use

Esaxerenone improves vascular function, peripheral arterial stiffness in IHA patients

Esaxerenone improves vascular function, peripheral arterial stiffness in IHA patients

Ultrasonic propulsion clears residual stone fragments in kidney

Ultrasonic propulsion clears residual stone fragments in kidney

Obesity in polytrauma patients appears protective vs death

Obesity in polytrauma patients appears protective vs death

Perioperative pembrolizumab may shift treatment paradigm in resectable HNSCC

Perioperative pembrolizumab may shift treatment paradigm in resectable HNSCC

Injectable extended-release naltrexone poses no hepatotoxicity signal in advanced ALD

Injectable extended-release naltrexone poses no hepatotoxicity signal in advanced ALD

The link between microbes and the gut is being brought to light with the power of AI.

The link between microbes and the gut is being brought to light with the power of AI.

ARANOTE: Darolutamide positively impacts HRQoL in men with mHSPC

ARANOTE: Darolutamide positively impacts HRQoL in men with mHSPC